UTI Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 20-01-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
UTI Healthcare Fund - Regular Plan - Growth Option 5.25 13.47 4.47 0.56 0.86 16.28
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care 4.56 10.87 1.50 -1.91 -1.53 13.41
S&P BSE Health Care - TRI 4.56 10.91 2.28 -1.27 -0.95 11.95

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 Unrated 4.47 0.56 0.86 2.36 394.61
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 Unrated 3.28 5.57 4.26 2.07 2,416.99
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 Unrated 0.81 -2.37 0.61 2.40 926.47

Fund Holdings as on 31-December-2019

  • EQ SUN PHARMACEUTICALS INDUSTRIES LTD.

  • EQ CIPLA LTD.

  • EQ DIVIS LABORATORIES LTD.

  • EQ LUPIN LTD.

  • EQ AUROBINDO PHARMA LTD.

  • EQ IPCA LABORATORIES LTD.

  • EQ DR REDDY'S LABORATORIES LTD.

  • EQ CADILA HEALTHCARE LTD.

  • EQ ERIS LIFESCIENCES LTD

  • EQ FDC LIMITED

  • EQ AJANTA PHARMA LIMITED

  • EQ SANOFI INDIA LTD.

  • EQ BIOCON LTD.

  • EQ NATCO PHARMA LTD.

  • EQ SYNGENE INTERNATIONAL LTD.

  • EQ TORRENT PHARMACEUTICALS LTD.

  • EQ GLAXOSMITHKLINE PHARMACUETICALS LTD.

  • EQ DR. LAL PATHLABS LTD.

  • EQ ABBOTT INDIA LTD.

  • EQ PFIZER LIMITED

  • EQ ALKEM LABORATORIES LTD

  • EQ METROPOLIS HEALTHCARE LTD

  • EQ ADVANCED ENZYME TECHNOLOGIES LTD

  • NET CURRENT ASSETS

  • FEDERAL BANK LTD STD - 371 DaysMargin deposit

View More
  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

View More

About UTI Healthcare Fund

Scheme Analysis

UTI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to UTI Mutual Fund. It was launched on 01-Aug-2005 and currently has an AUM of ₹394.61 crore. UTI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of UTI Healthcare Fund ended down ₹-0.25(-0.28%)yesterday to ₹88.4736.

Among its top 3 holdings the fund has exposure to EQ SUN PHARMACEUTICALS INDUSTRIES LTD., and

The UTI Healthcare Fund is managed by V. Srivatsa .

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com

Fund Manager

  • Cash

  • Deposits

  • Equity

View More